BPC-157 improved sphincter dysfunction-related esophagitis and pancreatitis in both rat models AND human acute pancreatitis patients with low sphincter pressures — translational evidence spanning animal to human.
Key findingBPC-157 improved sphincter dysfunction-related esophagitis and pancreatitis in both rat models AND human acute pancreatitis patients with low sphincte
What the researchers found
BPC-157 improved sphincter dysfunction-related esophagitis and pancreatitis in both rat models AND human acute pancreatitis patients with low sphincter pressures — translational evidence spanning animal to human.
Why it matters
Relevant for peptide research.
How the study worked
research study.
What this study cannot tell us
See abstract.
How to read the evidence
emerging evidence.
When this study was published
Published in 2011.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
Common questions
What was studied?
What was found?
Read the original research
BPC 157 therapy to detriment sphincters failure-esophagitis-pancreatitis in rat and acute pancreatitis patients low sphincters pressure.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 62(5), 527-34
Citation
Petrovic, I; Dobric, I; Drmic, D; Sever, M; Klicek, R; Radic, B; Brcic, L; Kolenc, D; Zlatar, M; Kunjko, K; Jurcic, D; Martinac, M; Rasic, Z; Boban Blagaic, A; Romic, Z; Seiwerth, S; Sikiric, P. (2011). BPC 157 therapy to detriment sphincters failure-esophagitis-pancreatitis in rat and acute pancreatitis patients low sphincters pressure.. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 62(5), 527-34.